Table 3. Worst toxicities by patients reported in the phase II study.
|
NCI-CTC grade
|
||||
|---|---|---|---|---|
| Grade 1 | Grade 2 | Grade 3 | Grade 4 | |
| Toxicity | no. (%) | no. (%) | no. (%) | no. (%) |
| Haematologic | ||||
| Neutropenia | 4 (13) | 1 (3) | 5 (16) | 5 (16) |
| Febrile neutropenia | 1 (3) | 2 (6) | 2 (6) | |
| Thrombocytopenia | 2 (6) | 3 (10) | ||
| Gastrointestinal | ||||
| Nausea/vomiting | 11 (35) | 4 (13) | ||
| Colitis | 1 (3) | 2 (6) | ||
| Diarrhoea | 2 (6) | 5 (16) | 6 (19) | |
| Stomatitis | 1 (3) | |||
| Proctitis | 3 (10) | 2 (6) | ||
| Skin, local toxicity | 1 (3) | 2 (6) | ||
| Fatigue/asthenia | 3 (10) | 1 (3) | ||
| Fever | 1 (3) | 2 (6) | ||
| Paresthesia/dysesthesia | 5 (16) | |||
NCI-CTC=National Cancer Institute Common Toxicity Criteria.